Maintaining residual renal function in patients on haemodialysis: 5-Year experience using a progressively increasing dialysis regimen

Nefrologia

Volumn 32, Issue 6, 2012, Pages 767-776

  Fernández Lucas, Milagros ^a   Teruel Briones, José L ^a   Gomis Couto, Antonio ^a   Villacorta Pérez, Javier ^a   Quereda Rodríguez Navarro, Carlos ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Incremental hemodialysis; Residual renal function in hemodialysis; Survival

Indexed keywords

ARTICLE; FEMALE; HUMAN; KIDNEY; MALE; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; TIME;

FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS;

EID: 84873714980     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2012.Jul.11517     Document Type: Article

References (56)

1. NKF-DOQI Update 2000, Guideline 1, Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2001;37 Suppl 1:S109-S115.
2. García Pérez H, Pérez Beñasco V, Arrieta J, Pérez Fontán M. La prescripción de diálisis peritoneal. Evaluación de la dosis de diálisis adecuada. Nefrologia 2006;26 Suppl 4:67-85.
3. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance on adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158-68.
4. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT; for the NECOSAD Study Group. The relative contribution of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003;41:1293-302.
5. Tattersall J, Martín-Malo A, Pedrini L, Basci A, Canaud B, Fouque D, et al. EBPG guideline on dialysis strategies. Nephrol Dial Transplant 2007;22 (Suppl 2): ii5-ii21.
6. National Kidney Foundation: K/DOQI Clinical Practice Recommendations for Hemodialysis Adequacy. Guideline 4: Minimally adequate hemodialysis. Am J Kidney Dis 2006;48 (Suppl 1):S53-S62.
7. Gotch FA, Keen ML. Care of the patient on hemodialysis. In Cogan MG and Garovoy MR (eds), Introduction to Dialysis. New York: Churchill, 1985, pag 73-143.
8. Gotch FA. Kinetic modeling in hemodialysis. In: Nissenson AR, Fine RN,Gentile DE (eds.). Clinical Dialysis. Norwalk, CT: Appleton & Lange; 1992. p. 118-46.
9. Lars Penne E, Van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MPC, Nubé MJ, et al., on behalf of the CONTRAST investigators. Role of residual kidney function and convective volumen on change in beta2-microglobulin levels in hemodiafiltration patients. Clin J Am Soc Nephrol 2010;5:80-86.
10. Fry AC, Singh DK, Chandna SM, Farrington K. Relative importance of residual renal function and convection in determining beta-2- microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 2007;25:295-302.
11. Gerhardt T, Pöge U, Stoffel-Wagner B, Klein B, Klehr HU, Sauerbruch T, et al. Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. Nephrol Dial Transplant 2008;23:309-14.
12. Rodríguez Benítez P, Gómez Campderá F. Importancia de la función renal residual en pacientes en hemodiálisis. Nefrologia 2002;XXII:98-103.
13. Malyszko J, Malyszko JS, Kozminski P, Mysliwiec M. Type of renal replacement therapy and residual renal function may affect prohepcidin and hepcidin. Ren Fail 2009;31:876-83.
14. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556-64.
15. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT; NECOSAD Study Group. Predictors of the rate of decline of residual renal function in Incident dialysis patients. Kidney Int 2002;62:1046-53.
16. Krediet RT. How to preserve residual renal function in patients with chronic kidney disease and on dialysis?. Nephrol Dial Transplant 2006;21(Suppl 2):ii42-ii46.
17. Gotch FA, Keen ML. Care of the patient on hemodialysis. Introduction to dialysis. New York: Churchill; 1985.
18. National Kidney Foundation: K/DOQI Clinical Practice Recommendations for Hemodialysis Adequacy. Guideline 6: Preservation of residual kidney function. Am J Kidney Dis 2006;48 (Suppl 1):S68-S70.
19. Barsotti G, Guiducci A, Ciardella F, Giovannetti S. Effects on renal function of a low-nitrogen diet supplemented with essential aminoacids and ketoanalogues and of hemodialysis and free protein supply in patients with chronic renal failure. Nephron 1981;23:113-8.
20. Altmann P, Butter KC, Plowman D, Chaput de Saintonge DM, Cunningham J, Marsh FP. Residual renal function in hemodialysis patients may protect against hyperaluminemia. Kidney Int 1987;32:710-3.
21. McCarthy JT, Jenson BM, Squillace DP, Williams AW. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers. Am J Kidney Dis 1997;29:576-83.
22. Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001;38:85-90.
23. Depner TA, Keshaviah PR, Ebben JP, Emerson PF, Collins AJ, Jindal KK, et al. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J Am Soc Nephrol 1996;7:464-71.
24. Sargent JA. Control of dialysis by a single-pool urea model: The National Cooperative Dialysis Study. Kidney Int Suppl 1983;(13):S19-S25.
25. Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al. Rate of decline of residual renal function is associated with allcause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant 2009;24:2909-14.
26. Termorshuizen F, Dekker FW, Van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT, for the NECOSAD Study Group. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004;15:1061-70.
27. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K. Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 2009;24:2502-10.
28. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-91.
29. Brener ZZ, Thijssen S, Kotanko P, Kuhlmann MK, Bergman M, Winchester JF, et al. The impact of residual renal function on hospitalization and mortality in incident hemodialysis patients. Blood Purif 2011;31:243-51.
30. Yang PY, Lin JL, Lin-Tan DT, Hsu CW, Yen TH, Chen KH, et al. Residual daily urine volume association with inflammation and nutrition status in maintenance hemodialysis patients. Ren Fail 2009;31:423-30.
31. Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, et al. The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 2000;15:396-401.
32. Guzzo I, Mancini E, Wafo SK, Ravà L, Picca S. Residual renal function and nutrition in young patients on chronic hemodialysis. Pediatr Nephrol 2009;24:1391-7.
33. Chilcot J, Wellsted D, Vilar E, Farrington K. An association between residual renal function and depression symptoms in haemodialysis patients. Nephron Clin Pract 2009;113:c117-c124.
34. Tian JP, Du FH, Cheng LT, Wang T. Residual renal function and arterial stiffness mediated the blood pressure change during interdialytic weight gain in hemodialysis patient. Hemodial Int 2009;13:479-86.
35. Fernández Lucas M, Villacorta J, Teruel JL, Zamora J, Rodríguez Mendiola N, Ortuño J. Mantenimiento de la función renal residual con una pauta incremental de hemodiálisis. Nefrologia 2009;29 (Suppl 2):64.
36. Chandra SM, Farrington K. Residual renal function: Considerations on its importance and preservation in dialysis patients. Sem Dial 2004;17:196-201.
37. Kuno T, Matsumoto K. Clinical benefit of preserving residual renal function in patients after initiation of dialysis. Blood Purif 2004;22(Suppl 2):67-71.
38. Ng TG, Johnson DW, Hawley CM. Is it time to revisit residual renal function in haemodialysis? Nephrology (Carlton) 2007;12:209-17.
39. Haag-Weber M. The impact of residual renal function on survival. Nephrol Dial Transplant 2008;23:2123-6
40. Perl J, Bargman JM. The importance of residual kidney function for patients on dialysis: A critical review. Am J Kidney Dis 2009;53:1068-81.
41. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991;37(4):598-604.
42. Moist LM, Port F, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556-64.
43. Misra M, Vonesh E, Van Stone JC, Moore HL, Prowant B, Nolph KD. Effect of cause and time of dropout on the residual GFR: A comparative analysis of the decline of GFR on dialysis. Kidney Int 2001;59(2):754-63.
44. Jansen M, Hart A, Korevaar J, Dekker FW, Boeschoten EW, Krediet RT; NECOSAD study group. Predictors of the rate of decline of residual renal function in incidence dialysis patients. Kidney Int 2002;62(3):1046-53.
45. Gunal AI, Kirciman E, Guler M, Yavuzkir M, Celiker H. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?. Ren Fail 2004;26:405-9.
46. Gámez C, Teruel JL, Ortuño J. Evolución de la función renal residual en enfermos tratados con hemodiálisis. Nefrologia 1992;XII (Suppl 5):125-9.
47. Drechsler C, de Mutsert R, Grootendorst DC, Boeschoten EW, Krediet RT, le Cessie S, et al., for the NECOSAD Study Group. Association of body mass index with decline in residual kidney function after initiation of dialysis. Am J Kidney Dis 2009;53:1014-23.
48. Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 2002;17:1814-8.
49. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K. Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 2002;61:256-65.
50. Caramelo C, Alcázar R, Gallar P, Teruel JL, Velo M, Ortega O, et al. Choice of dialysis membrane does not influence the outcome of residual renal function in haemodialysis patients. Nephrol Dial Transplant 1994;9:675-7.
51. Noordzij M, Voormolen NMC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, et al., for the NECOSAD study group. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients. Nephrol Dial Transplant 2009;24:1580-7.
52. Tornero Molina F, Remón Rodríguez C. Indicaciones para el inicio de técnicas de depuración extrarrenal. In: Guía SEN de Enfermedad Renal Crónica Avanzada y Prediálisis. Nefrología 2008;28(Supl 3):101-4.
53. Stel VS, Tomson C, Ansell D, Casino FG, Collart F, Finne P, et al. Level of renal function in patients starting dialysis: an ERA-EDTA Registry study. Nephrol Dial Transplant 2010;25:3315-25.
54. Canaud B. Residual renal function: the delicate balance between benefits and risks. Nephrol Dial Transplant 2008;23:1801-5.
55. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, et al. Comparison of residual renal function in patients undergoing twiceweekly versus three-times-weekly hemodialysis. Nephrology (Carlton) 2009;14:59-64.
56. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, et al. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 2007;49:426-31.